Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Commodities

Leadership Shakeup at Barrick Gold Follows Elliott Management Stake

Andreas Sommer by Andreas Sommer
November 19, 2025
in Commodities, Gold & Precious Metals, Mergers & Acquisitions, Turnaround
0
Barrick Stock
0
SHARES
134
VIEWS
Share on FacebookShare on Twitter

A dramatic corporate overhaul is underway at Barrick Gold, the world’s largest gold producer. The company has replaced its entire North American leadership team and announced fundamental structural changes. This reorganization coincides with the recent disclosure that activist investor Elliott Investment Management has taken a substantial $700 million position in the mining giant, establishing itself among Barrick’s top ten shareholders.

The timing of these developments is unlikely to be coincidental. Elliott, known for its aggressive campaigns to unlock value at undervalued companies, has sent a clear message to Barrick’s management: the status quo is unacceptable. This raises a critical question about a firm that CEO Mark Hill describes as having “excellent fundamental data”—what exactly is going wrong?

Executive Suite Sees Complete Overhaul

The personnel changes are sweeping. Christine Keener has departed the company, with Tim Cribb stepping into the role of Chief Operating Officer (COO) for North America. In a parallel move, Kevin Annett has been replaced as Chief Financial Officer (CFO) by Wessel Hamman. Adding to the new leadership dynamic, George Joannou has been promoted to Chief Development Officer, joining the executive committee.

The transformation extends beyond personnel. Barrick is also implementing a significant geographical reorganization. The highly profitable Pueblo-Viejo mine in the Dominican Republic will now be managed under the North American business unit. Concurrently, the company is merging its Latin America and Asia-Pacific divisions into a single, consolidated operation.

Should investors sell immediately? Or is it worth buying Barrick?

Strategic Pressure from an Activist Investor

The corporate restructuring appears to be a direct response to Elliott’s growing influence. The hedge fund’s strategy often involves pushing for corporate break-ups or spin-offs to realize hidden value. Market observers suggest that a potential separation of Barrick’s North American assets from its higher-risk operations in Africa and Asia is now on the table.

The rationale behind such a move is clear: despite a robust gold price environment, Barrick’s stock performance has lagged behind its industry peers. A structural separation could highlight the value of its stable North American portfolio and drive a higher market valuation. This strategic pivot toward North America is further emphasized by Barrick’s recent signing of a new option agreement for the Lewis gold project located in Quebec.

Will These Measures Be Enough?

In a remarkably candid internal memo, CEO Mark Hill conceded that the company’s previous operational approach was no longer sustainable. The critical test will be whether this restructuring and renewed focus on North American assets will satisfy Elliott Investment Management. The market will be watching for the next comprehensive financial results in February 2026, which will cover the full 2025 fiscal year.

Until then, a pivotal question remains: Will Barrick’s voluntary changes be sufficient, or will Elliott feel compelled to escalate its pressure campaign to force more drastic action?

Ad

Barrick Stock: Buy or Sell?! New Barrick Analysis from March 25 delivers the answer:

The latest Barrick figures speak for themselves: Urgent action needed for Barrick investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Barrick: Buy or sell? Read more here...

Tags: Barrick
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

March 25, 2026
SOXX ETF Stock
Commodities

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026
Next Post
Applovin Stock

Applovin's Insider Sell-Off: A Signal for Shareholders?

Nestle Stock

Nestlé Shares Rally Following Favorable Court Ruling

Barrick Mining Stock

Barrick Gold Faces Major Corporate Overhaul as Activist Investor Takes Stake

Recommended

Lockheed Martin Stock

Defense Giant Lockheed Martin Secures Billions in New Military Contracts

6 months ago
OKE stock news

Amalgamated Bank Increases Stake in CF Industries as Market Opinions Vary

3 years ago
IBM Stock

IBM’s AI Windfall Fails to Impress Stock Market

7 months ago
Blackstonecured Lending Fund Stock

Blackstone BDC Insider Purchase Defies Analyst Downgrades

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Trending

Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

by Kennethcix
March 25, 2026
0

The future of Gossamer Bio hinges on a critical regulatory discussion scheduled for June 2026. The biopharmaceutical...

SOXX ETF Stock

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026
  • Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns
  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com